What becomes possible when epigenetics, fragmentomics, and machine learning converge on a brand-new diagnostic platform, and what does it take to lead the science that makes it work?
Tagomics is a Cambridge-based biotechnology company developing a next-generation multi-omic biomarker discovery platform to transform how disease and drug safety are understood, measured, and monitored.
The Cambridge Centre for Alternative Finance (CCAF) at Cambridge Judge Business School is looking for a highly organised and proactive Centre Manager to lead on operational delivery and support the strategic growth of our globally recognised research centre.
In this pivotal role, you will oversee day-to-day operations, financial management, project coordination, and stakeholder engagement, while supporting grant applications and ensuring compliance with university and funder requirements.
You will bring:
As a key member of the Analytical & Materials Science (AMS) team in Sandwich, Kent, you will be in charge of managing the supplies, stocks, and day-to-day activities of the lab and the delivery of its services.
The environment we work in can be fast-paced, dynamic and changing, adding variety and spice to your day-to-day work.
What you'll do at work
Key responsibilities and accountabilities:
Who we are:
Life, Reimagined
Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.
Cyclic peptides have a special power in the therapeutic space — they're larger and more specific than small molecules, and more permeable and cost-effective than antibodies. These qualities enable them to conquer two of the biggest challenges in modern drug development: prosecuting flat intracellular protein-protein interactions (PPIs) and achieving oral bioavailability for demanding targets.
Qureight’s mission is to accelerate clinical trials and ensure breakthroughs in lung and heart disease reach patients without delay. Our AI-powered data and imaging curation platform enables the analysis of clinical imaging and other healthcare data, helping our customers bring treatments to market, faster.
About Us
The King’s Institute for Population Health is a newly created institute hosted in the School of Life Course & Population Sciences, in the Faculty of Life Sciences & Medicine at King’s College London.
The Faculty is one of the largest and most successful centres for research and education in the UK, we benefit from extensive international and local partnerships that encourage innovative and progressive collaboration.
Scendea is an international product development, regulatory, and compliance consulting group delivering market-leading scientific expertise & regulatory solutions, to advance healthcare innovation worldwide.
Job Description
Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and the US. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, oncology, inflammation and metabolic diseases.
Amsbio has launched a new range of authenticated cell lines covering a wide range of tumours, tissues, and species. With this addition of greater than 1000 independently verified human and animal cell lines, versatile primary and stem cells, the expanded range of top quality, cell lines from Amsbio are second to none.